Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26F8YYU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,256
Award facts
- Contract value 100% obligated
- $24,255.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $24,255.82 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors on November 4, 2025, with an ultimate completion date of November 5, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract and will be performed at the contractor's Conshohocken, Pennsylvania facility. Dupixent (dupilumab) is a biologic medication commonly prescribed for moderate-to-severe atopic dermatitis, eosinophilic asthma, and chronic rhinosinusitis with nasal polyps, reflecting the Defense Logistics Agency's procurement of specialty pharmaceutical products for military healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as the primary vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen Drug Corp maintains an extensive portfolio of federal medical supply contracts with the Defense Logistics Agency, demonstrating its established capability to meet competitive federal procurement standards for critical pharmaceutical commodities.
Quick answers
Who was awarded contract SPE2DR26F8YYU?
SPE2DR26F8YYU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DR26F8YYU worth?
The government has obligated $24,256 on SPE2DR26F8YYU.
Is contract SPE2DR26F8YYU an order under another contract?
Yes. SPE2DR26F8YYU is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F8YYU competed?
The extent of competition for SPE2DR26F8YYU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award